Resources

By partnering with TriNetX, one global pharma organization embedded real‑world data and transparent AI‑enabled query translation directly into existing design workflows.

Clinical development costs now average roughly $708 million per approved therapy. The industry’s need for accessible and trustworthy insight from real‑world data has never been greater.

We spotlight Tasfia’s work at Penn State and distilling practical lessons for other researchers navigating the complexities of cohort-based RWE studies.

Discover how real-world evidence untaps the potential of perioperative systemic therapy in muscle-invasive bladder cancer (MIBC) care.

We’re pleased to recognize Taichung Veterans General Hospital (TCVGH) as our Q2 2026 Network Spotlight winner!

TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and current TriNetX partner.

Regeneron Pharmaceuticals, Inc. and TriNetX® today announced a strategic collaboration to support Regeneron’s capabilities in drug discovery and development, as well as new initiatives to deliver digital health solutions of the future for consumers, patients and providers.

We explore how clinical data integration unifies disparate systems to deliver actionable insights.

In our latest Inside the Trends vodcast episode, COO Steve Kundrot spoke with Dr. Sarju Ganatra , a cardiologist and Co-Director of the Lahey Innovation Hub. They stripped patient-centricity back to its core.

TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation.

Run time: 31mins. Patient-centricity is everywhere in clinical research. But what does it actually look like inside real healthcare systems?

We’re proud to announce Worcestershire Acute Hospitals NHS Trust as our Q1 2026 Network Spotlight winner!